Table 2.
Plasma levels of NO-related elements in different experimental groups.
| Control | HF | BPA | HF + BPA | BPA + R | HF + BPA + R | |
|---|---|---|---|---|---|---|
| l-citrulline (μM) | 56.4 ± 5.8 | 45 ± 2 | 52.9 ± 3.6 | 42.8 ± 4.5 | 48.8 ± 8.6 | 67.3 ± 4.3 ‡ |
| l-arginine (μM) | 153.6 ± 12.8 | 125.7 ± 9.6 | 137.1 ± 12.9 | 141.9 ± 7.2 | 175 ± 17 | 191.7 ± 11.7 #† |
| ADMA (μM) | 1.66 ± 0.21 | 1.36 ± 0.1 | 2.14 ± 0.22 | 2.67 ± 0.27 *#† | 2.26 ± 0.21 #‡ | 2.8 ± 0.2 *# |
| SDMA (μM) | 0.38 ± 0.07 | 0.31 ± 0.05 | 1.01 ± 0.12 *# | 0.74 ± 0.16*# | 0.58 ± 0.1 † | 0.7 ± 0.1 # |
| l-arginine-to-ADMA ratio (μM/μM) | 99.3 ± 10.8 | 97.2 ± 12.9 | 66.2 ± 6.6 | 58.2 ± 9.4*# | 79.5 ± 7 | 69.9 ± 6.6 |
n = 7–8/group; * p <0.05 versus control; # p < 0.05 versus HF; † p < 0.05 versus BPA; ‡ p < 0.05 versus HF + BPA.